Introduction
============

Lung cancer is the most common cancer worldwide, with 1.35 million incident cases annually, and consists one of the leading causes of mortality worldwide \[[@B1]\]. In addition to cigarette smoking, the major lung cancer risk factor \[[@B1]\], recent studies underscore an etiologic role for chronic pulmonary infection in lung carcinogenesis, acting either independently or as a cofactor to tobacco smoke in increasing lung cancer risk \[[@B2]-[@B5]\]. Experimental and clinical data correlate cancer development with the presence of certain pathogens, independently of chemotherapy-induced leucopenia \[[@B6]-[@B8]\]. Indeed, mycoplasma is one of the most often observed pathogen in lung carcinomas \[[@B9]\], and it has been postulated that mycoplasma-infected cells have a higher ability to metastasize in vivo than non-mycoplasma-infected cells \[[@B10]\]. Very similarly, the bacterium Chlamydia pneumoniae, a common cause of community-acquired pneumonia, has been implicated in lung carcinogenesis \[[@B11]-[@B16]\]. Staphylococcus strains likewise have been observed in many cases of patients with lung cancer \[[@B6],[@B7],[@B17]-[@B19]\]. Other studies have demonstrated the presence of colonies in respiratory tract in patients with cancer \[[@B19]\]; Haemophilus influenza \[[@B6],[@B7],[@B19]-[@B21]\] and Candida albicans \[[@B7],[@B20]-[@B22]\] have been found in patients with lower respiratory tract malignancies. Legionella pneymophila has been diagnosed in patients with cancer \[[@B23]\], as well as strains of Bacillus \[[@B7]\], Listeria \[[@B24]\], and Streptococcus \[[@B6],[@B7],[@B17],[@B19],[@B25]\].

Importantly, previous retrospective and prospective studies have relied on serologic characterization of chronic bacterial and fungal infections \[[@B14]\]. To the best of our knowledge, the prevalence of bacterial and/or fungal infection in surgically extracted samples of patients with lung cancer has not been previously reported. The aim of the present study, therefore, was to determine the presence of bacterial and fungal microflora in surgically removed tissue samples of patients with lung cancer, by using PCR methods and special primers.

Materials and methods
=====================

In this single-center prospective, observational study, tissue samples were surgically removed from 32 consecutive patients with lung cancer. The samples were maintained in RPMI culture medium (Sigma, R0883, Germany). The tissue was dissociated and 2 ml Trypsin - 0,25% EDTA (Invitrogen, 25200-072, California) was added in order to detach the cells. The trypsin has been inactivated by using FBS (Invitrogen, 10106-169, California) and cells were centrifuged at 1,200 rpm for 10 min. Then cells were incubated in 25 cm^2^flasks (Orange Scientific, 5520200, Belgium) at 37°C, in a 5% CO2 atmosphere, until well developed. RNA was extracted using TRIZOL (Invitrogen, 15596-026, California) and was used as a template to generate cDNA using the First strand cDNA synthesis kit (Fermentas, K1612, Canada). The First strand cDNA was used as a template for the Gradient-PCR reaction, which was performed using GoTaq Flexi polymerase (Promega, M8305, USA). Primers have been designed with Gene Expression 1.1 software. The PCR conditions were set as follows: initial denaturation at 95°C for 10 min to activate the polymerase, 35 cycles of denaturation at 94°C for 45 sec, followed by annealing at 52-58°C for 45 sec and an extension step at 72°C for 60 sec. A final extension step was performed at 72°C for 10 min. The PCR products were then separated on 1.5% agarose gel (Merck, 1012360500, USA) stained with GelGreen (Gentaur, 41005, Belgium), and finally observed under UV-light. A 100-bp ladder (Promega, G2101, USA) was used as marker.

This study was in compliance with the Helsinki Declaration. All participants gave informed consent and the study was approved by the institutional board review.

Results
=======

Table [1](#T1){ref-type="table"} shows the primer pairs that were used in PCR to identify the specific pathogen strains. Table [2](#T2){ref-type="table"} presents the frequency of different species and strains in the samples that were examined. The analysis of the electrophoresis data pointed out diversity between the samples and the strains that were identified in them. Mycoplasma strains were identified in all samples (Figure [1](#F1){ref-type="fig"} demonstrates electrophoresis results for Mycoplasma strains). Strains that appeared more often were Staphylococcus epidermidis, Streptococcus mitis and Bacillus strains, followed in descending frequency by Chlamydia, Candida, Listeria, and Haemophilus influenza. In individual patients Legionella pneumophila and Candida tropicalis were detected.

###### 

Primer pairs that have been used in PCR

  Organism         Species             Forward Primer (5\'-3\')   Reverse Primer (5\'-3\')   PCR Product (bp)
  ---------------- ------------------- -------------------------- -------------------------- ------------------
  Treponema        pallidum            AATGCGGTGGCGTAGCGATAC      TTTTGCGGTTTGCTCCACTTC      275
                                                                                             
                   denticola           AGGGATATGGCAGCGTAGCAATA    CGTCCTCCCTTACGGGTTAGACT    453
                                                                                             
                   vincentii           GCGGTATGTAAGCCTGGTGTGAA    TTTGCTTTGGCACTGAAGCTCTT    277
                                                                                             
  Neisseria        meningitidis        AAGTCGGACGGCAGCACAGA       TCAGCCGCTGATATTAGCAACAG    421
                                                                                             
  Legionella       pneumophila         AAGATTAGCCTGCGTCCGATTAG    AACCCTCCTCCCCACTGAAAGT     232
                                                                                             
  Borrelia         burgdorferi         CATGCAAGTCAAACGGGATGTA     GACCTTCTTCATTCACGCAGTG     361
                   americana                                                                 
                   valaisiana                                                                
                   garinii                                                                   
                   recurrentis                                                               
                   hispanica                                                                 
                   duttonii                                                                  
                   lusitaniae                                                                
                   spielmanii                                                                
                                                                                             
  Listeria         grayi               TCTTGACATCCTTTGACCACTCTG   TGCACCGGCAGTCACTTTAGAG     157
                   innocua                                                                   
                   monocytogenes                                                             
                   welshimeri                                                                
                                                                                             
  Helicobacter     pylori              GATTGGCTCCACTTCGCAGTA      GGCGACCTGCTGGAACATT        560
                   pullorum                                                                  
                   equorum                                                                   
                   canadensis                                                                
                                                                                             
  Staphylococcus   aureus              AGGCGACTTTCTGGTCTGTAACTG   CCGAAGGGGAAGGCTCTATCT      307
                                                                                             
  Haemophilus      parasuis            CCTTGGGAAAATACTGACGCTCAT   TCCCGAAGGCACACTCTCAT       297
                                                                                             
  Chlamydia        muridarum           TGTTTAGTGGCGGAAGGGTTAG     CCGTCCATTGCGAAAGATTC       304
                   trachomatis                                                               
                                                                                             
  Bacillus         pumilus             TGCAAGTCGAGCGGACAGA        TCCCAGTCTTACAGGCAGGTTAC    91
                   aerophilus                                                                
                   licheniformis                                                             
                   amyloliquefaciens                                                         
                   subtilis                                                                  
                                                                                             
  Bacillus II      anthracis           CGGCTTCGGCTGTCACTTATG      TCAGCACTAAAGGGCGGAAAC      655
                   cereus                                                                    
                   thuringiensis                                                             
                                                                                             
  Mycoplasma       pneumoniae          GAGGCGAACGGGTGAGTAACA      CGCGACTGCTGGCACATAGT       441
                   pirum                                                                     
                   gallicepticum                                                             
                   genitalium                                                                
                   amphoriforme                                                              
                                                                                             
  Leptospira       borgpetersenii      GGATAGCCCCGAGAGGTCATA      CCATCATCACATCGCTGCTTAT     299
                                                                                             
  Leptospira       meyeri              CGAATGTGACGGTTCCTGGTAG     TTCGCCCATTGAGCAAGATT       210
                   biflexa                                                                   
  Staphylococcus   epidermidis         GTGAAAGACGGTTTTGCTGTCAC    CGGATAACGCTTGCCACCTAC      359
                                                                                             
  Streptococcus    mitis               GGAGCTTGCTCTTCTGGATGAG     GAGCCGTTACCCCACCAACT       197
                                                                                             
  Leptospira       interrogans         CAGCCTGCACTTGAAACTATGTG    ATAGTCCCCAGGCGGTCTACT      266
                                                                                             
  Brachyspira      hyodysenteriae      TGCCGTAGAGTGGGGGATAA       CCGCAGGCTCATCGTAAAG        109
                   aalborgi                                                                  
                   intemedia                                                                 
                   alvinipulli                                                               
                   innocens                                                                  
                   suanatina                                                                 
                                                                                             
  Haemophilus      influenzae          CTTGCTTTCTTGCTGACGAGTG     TCTCAGTCCCGCACTTTCATC      129
                                                                                             
  Candida I        albicans            CCAGCCGAGCCTTTCCTTCT       TACCCCCGACCGTCCCTATT       187
                   parapsilosis                                                              
                   dubliensis                                                                
                                                                                             
  Candida          tropicalis          CGGTCGGGGGTATCAGTATTC      ATACTCGCTGGCTCCGTCAGT      622

###### 

Prevalence by different species and strains

  Pathogen         Strain              Prevalence (%)
  ---------------- ------------------- ----------------
  Legionella       pneumophila         3.125
  Listeria         grayi               9.375
                   innocua             
                   monocytogenes       
                   welshimeri          
  Chlamydia        muridarum           12.5
                   trachomatis         
  Bacillus         pumilus             28.125
                   aerophilus          
                   licheniformis       
                   amyloliquefaciens   
                   subtilis            
  Staphylococcus   epidermidis         25
  Streptococcus    mitis               21.875
  Haemophilus      influenzae          6.25
  Mycoplasma       pneumonia           100
                   pirum               
                   gallicepticum       
                   genitalium          
                   amphoriforme        
  Candida          albicans            12.5
                   parapsilosis        
                   dubliensis          
  Candida          tropicalis          3.125

![**Electrophoresis results for Mycoplasma strains**.](1749-8090-6-137-1){#F1}

Discussion
==========

Lung cancer is the most common cancer worldwide and is a leading causes of mortality worldwide \[[@B1]\]. Many recent studies have underscored the etiologic role of chronic pulmonary infection in lung carcinogenesis, concluding that inflammation increases the risk for incident lung cancer \[[@B2]-[@B5]\]. Numerous studies on lung cancer have pointed out the appearance of Mycoplasma strains in patients and suggest association of infection with tumorigenesis; it has been postulated that mycoplasma-infected cells have a higher ability to metastasize in vivo than non-mycoplasma-infected cells \[[@B10]\]. Candida species have been isolated from patients with lower respiratory tract infection \[[@B7],[@B20]-[@B22]\]. Haemophilus influenza \[[@B6],[@B7],[@B19]-[@B21]\], Staphylococcus epidermidis \[[@B6],[@B7],[@B17]-[@B19]\], Streptococcus species \[[@B6],[@B7],[@B17],[@B19],[@B25]\], Legionella pneymophila \[[@B23]\], as well as strains of Bacillus \[[@B7]\], Listeria \[[@B24]\] and Streptococcus \[[@B6],[@B7],[@B17],[@B19],[@B25]\] have been also identified in patients with different pulmonary diseases. Very similarly, the bacterium Chlamydia pneumoniae, a common cause of community-acquired pneumonia, has been implicated in lung carcinogenesis \[[@B11]-[@B16]\]. A recent meta-analysis by Zhan et al. \[[@B16]\] of 12 studies involving 2595 lung cancer cases and 2585 controls from four prospective studies and eight retrospective studies, was conducted to analyze the association between C. pneumoniae infection and risk of lung cancer. Overall, people exposed to C. pneumoniae infection had an odds ratio (OR) of 1.48 (95% confidence interval (CI), 1.32-1.67) for lung cancer risk, relative to those not exposed. Of interest, a higher titre was an even better risk prognosticator (OR for IgA ≥64 cutoff group, 2.35; 95% CI, 1.88-2.93; OR for IgA ≥16 cutoff group, 1.22; 95% CI, 1.06-1.41).

These data strongly support the idea that lung cancer is a biofilm associated chronic infection. Biofilms are microorganism populations organized in a form of colonies using self-produced extracellular matrix that works as infrastructure material. The vast majority of the micro-\"colonists\" establish biofilms on any inert or diseased biological surface. They adhere to each other, divide, cooperate, and, progressively, their bio-mass grows, matures and finally disperses. It resembles malignant behavior (tumors composed by cancer cells and by stroma cells-monocytes, lymphocytes, microvessels, can metastasize). Therefore, many researchers imply that lung malignancies are communities of diverse pathogens resistant to antibiotics.

One of the major limitations in most of the previous studies was the use of serologic characterization to identify chronic bacterial or fungal infections \[[@B14]\]. This has resulted in conflicting results and great variability in relative risk estimations among seropositive individuals \[[@B14],[@B15],[@B26]-[@B29]\]. This wide variability could also reflect the retrospective nature of most of the studies, the small sample sizes, or inadequate adjustment for confounding factors \[[@B14]\]. New techniques, such as PCR-RFLPs, Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) and microcolony methods allow examination and analysis of microbial communities \[[@B30],[@B31]\]. Analyzing the constituents of microbial biofilms responsible for lung disease may help us discover novel strategies to control malignancies.

To the best of our knowledge, the prevalence of bacterial and/or fungal infection in surgically extracted samples of patients with lung cancer has not been previously reported. Therefore, the main purpose of the present study was to determine the presence of bacterial and fungal microflora in surgically removed tissue samples of patients with lung cancer, by using PCR methods and special primers. In this study, specific primers were designed in order to amplify as many different strains of microorganisms. Pairs of primers that were designed were capable of amplifying Treponema, Neisseria, Legionella, Borrelia, Listeria, Helicobacter, Staphylococcys, Haemophilus, Bacillus, Leptospira, Streptococcus, Mycoplasma, Candida and Brachyspira species. It is worth noting that Mycoplasma species were observed in all samples. Staphylococcus epidermidis and Streptococcus mitis were almost seen in one quarter of patients. Neither Treponema strains nor Leptospira, Helicobacter, and Staphylococcus aureus strains were observed in this study.

Conclusion
==========

A diversity of pathogens could be identified in surgically extracted tissue samples of patients with lung cancer, with mycoplasma strains being present in all samples. These results point to an etiologic role for chronic infection in lung carcinogenesis. Confirmation of these observations and additional studies are needed to further characterize the etiologic role of inflammation in lung carcinogenesis, thus making it possible to apply new therapeutic modalities.
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